These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15277647)

  • 1. Deterioration of the auditory brainstem response in children with type 3 Gaucher disease.
    Campbell PE; Harris CM; Vellodi A
    Neurology; 2004 Jul; 63(2):385-7. PubMed ID: 15277647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of neuronopathic Gaucher disease.
    Campbell PE; Harris CM; Harris CM; Sirimanna T; Vellodi A
    J Inherit Metab Dis; 2003; 26(7):629-39. PubMed ID: 14707511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
    Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
    Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
    Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.
    Tantawy AA; Sherif EM; Adly AA; Hassanine S; Awad AH
    J Inherit Metab Dis; 2013 Nov; 36(6):1025-37. PubMed ID: 23508695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ; Kacena KA; Kaplan P; Pastores GM; Prakash-Cheng A; Zimran A; Hangartner TN
    J Bone Miner Res; 2007 Jan; 22(1):119-26. PubMed ID: 17032149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audiometric abnormalities in children with Gaucher disease type 3.
    Bamiou DE; Campbell P; Liasis A; Page J; Sirimanna T; Boyd S; Vellodi A; Harris C
    Neuropediatrics; 2001 Jun; 32(3):136-41. PubMed ID: 11521209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of correct phenotyping in Gaucher disease.
    Harris CM; Campbell P
    J Child Neurol; 2007 Aug; 22(8):1056-7. PubMed ID: 17761664
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
    El-Beshlawy A; Ragab L; Youssry I; Yakout K; El-Kiki H; Eid K; Mansour IM; Abd El-Hamid S; Yang M; Mistry PK
    J Inherit Metab Dis; 2006 Feb; 29(1):92-8. PubMed ID: 16601874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study.
    Anderson LJ; Henley W; Wyatt KM; Nikolaou V; Waldek S; Hughes DA; Pastores GM; Logan S
    J Inherit Metab Dis; 2014 Nov; 37(6):961-8. PubMed ID: 24638276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of later wave components in auditory brainstem responses as an initial manifestation of type 2 Gaucher disease.
    Okubo Y; Goto M; Sakakibara H; Terakawa T; Kaneko T; Miyama S
    Pediatr Neurol; 2014 Dec; 51(6):837-9. PubMed ID: 25301225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-genetic characteristics and treatment outcomes of Turkish children with Gaucher disease type 1 and type 3: A sixteen year single-center experience.
    Gumus E; Karhan AN; Hizarcioglu-Gulsen H; Demir H; Ozen H; Saltik Temizel IN; Dokmeci Emre S; Yuce A
    Eur J Med Genet; 2021 Nov; 64(11):104339. PubMed ID: 34500086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage?
    Brunel-Guitton C; Rivard GE; Galipeau J; Alos N; Miron MC; Therrien R; Mitchell G; Lapierre G; Lambert M
    Mol Genet Metab; 2009 Feb; 96(2):73-6. PubMed ID: 19083253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model.
    Vigan M; Stirnemann J; Caillaud C; Froissart R; Boutten A; Fantin B; Belmatoug N; Mentré F
    Orphanet J Rare Dis; 2014 Jun; 9():95. PubMed ID: 24980507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
    Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
    Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saccade testing in the diagnosis and treatment of type 3 Gaucher disease.
    Pensiero S; Accardo A; Pittis MG; Ciana G; Bembi B; Perissutti P
    Neurology; 2005 Dec; 65(11):1837. PubMed ID: 16344538
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response?
    Arikan-Ayyildiz Z; Yüce A; Emre S; Baysoy G; Saltik-Temizel IN; Gürakan F
    Turk J Pediatr; 2011; 53(5):499-507. PubMed ID: 22272449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high density lipoprotein in Type 1 Gaucher disease.
    Watad S; Abu-Saleh N; Yousif A; Agbaria A; Rosenbaum H
    Blood Cells Mol Dis; 2018 Feb; 68():43-46. PubMed ID: 27876360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.